New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Moderna, Inc.

MRNA

Healthcare Biotechnology

Moderna, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 39.9% from fiscal 2024.

Revenue
+29.2%
EPS
n/m
Free cash flow
n/m
Total debt
+13,550.0%

Quarter to September 2026, against a year earlier

195.12 4.21 −2.11%

After hours trading: 199.30, up 2.14%, last trade Fri 7:57pm Eastern.

Market cap
$79.6B
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
3/9
ROIC
−35.1%
Net debt / EBITDA
1.8×
Payout ratio
—

Revenue to profit Q3 FY2026, quarter to Sep 30, 2026

Of every $100 of revenue, $12.34 was left as profit. Gross margin has risen two quarters running, from −145.5% to 75.8%. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue1.3100.0%
Cost of revenue−0.3−24.2%
Gross profit1.075.8%
Research & development−0.6−44.4%
Selling, general & admin−0.3−21.5%
Operating income0.19.9%
Other income, net0.03.1%
Income tax0.0−0.7%
Net income0.212.3%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$678M$389M$145M$1.3B
Operating income−$857M−$1.4B−$815M$130M
Net income−$826M−$1.3B−$782M$162M
Net margin (right axis)−121.8%−345.2%−539.3%12.3%
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Revenue
1,313.00 145.00 389.00 678.00

+8 more quarters

Revenue Growth
29.23% 2.11% 260.19% (29.81%)
Gross Profit
995.00 52.00 (566.00) 226.00
Operating Income
130.00 (815.00) (1,388.00) (857.00)
EBT
171.00 (767.00) (1,334.00) (799.00)
Income after Tax
162.00 (782.00) (1,343.00) (826.00)
Net Income Common
162.00 (782.00) (1,343.00) (826.00)
EPS (Diluted)
0.38 (1.97) (3.40) (2.11)
Shares (Diluted, Weighted)
430.00 398.00 395.00 389.00
Gross Margin
75.78% 35.86% (145.50%) 33.33%
EBIT Margin
9.90% (562.07%) (356.81%) (126.40%)
Net Profit Margin
12.34% (539.31%) (345.24%) (121.83%)
EBITDA
186.00 (762.00) (1,340.00) (803.00)
EBIT
130.00 (815.00) (1,388.00) (857.00)

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 11, 2026